Covid Alert

Print ISSN:-2395-6186

Online ISSN:-2395-6194


Current Issue

Year 2020

Volume: 6 , Issue: 1

Journal of Oral Medicine, Oral Surgery, Oral Pathology and Oral Radiology

Management of central giant cell granuloma: A case series

Full Text PDF

Article Type : Case Report

Author Details: Kavita Wadde*,Jayant Landge,Sandip Rathod,Ashwini Chapane

Volume : 6

Issue : 1

Online ISSN : 2395-6194

Print ISSN : 2395-6186

Article First Page : 36

Article End Page : 40


Central giant cell granuloma (CGCG) is an uncommon, benign, and proliferative lesion of the jaw with an unknown aetiology, was first described by Jaffe in 1953.The lesion is found predominantly in children and young adults, with more than 60% of all cases occurring before the age of 30 years. The female: male ratio is 2:1. Lesions are more common in the anterior region of the jaws, and mandibular lesions frequently extend across the midline. CGCG can be difficult to diagnose from other lesion of oral cavity like Hyperparathyroid tumour, Ameloblastoma, Odontogenic myxoma, Haemangioma, Cherubism, Central odontogenic fibroma, Aneurysmal bone cyst, Traumatic bone cyst. Numerous treatment modalities given in literature from non–surgical to surgical. This paper intends to focus on diagnosis, clinical presentation and different management options of CGCG. So our aim was to evaluate the response of treatment of CGCG to intralesional injection.

Keywords: Central giant cell granuloma, Midline, Intralesional steroid, Phase I therapy, Phase II therapy.

Doi No:-10.18231/j.jooo.2020.010